Who Paid My Doc
Exercise capacity study in HFrEF
Research payments
$1,723,265
Through program year 2024, $1,723,265 in research payments was reported against Exercise capacity study in HFrEF, across 218 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim France S.A.S.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $14,429 | 1 |
| 2020 | Research | $385,327 | 36 |
| 2019 | Research | $1,323,510 | 181 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Pedro Martinez-Clark Miami, FL Named on 11 payments
- Bhola Rama Marion, OH Named on 8 payments
- Todd Lewis St Augustine, FL Named on 8 payments
- Anil Chhabra Shreveport, LA Named on 7 payments
- Matthew Budoff Torrance, CA Named on 7 payments
- Lokesh Chandra Chicago, IL Named on 6 payments
- Binu Jacob Zephyrhills, FL Named on 5 payments
- Noel Bedwell Mobile, AL Named on 5 payments
- Sudhir Prasada Rocky Mount, NC Named on 5 payments
- Robert Long Jackson, MS Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.